Cannabis Capital Conference

Renowned cannabis investors Brett Finkelstein (Skyvest Partners and Phyto Partners,) Morgan Paxhia (Poseidon Investment Management) and David Kram (Spring Leaf Capital) gathered at Benzinga’s Cannabis Capital Conference in Chicago this past September. Led by David Feldman of...

For cannabis business owners wondering how to scale beyond payroll, here’s some straight advice: “Look for a system that can scale with you,” says Jenn Meadows, COO of Würk, a Human Capital Management (HCM) company. Würk has been providing payroll, human...

Cannabis-infused beverages are swiftly making their mark alongside traditional alcoholic drinks, and a recent panel discussion at the Benzinga Cannabis Capital Conference shed light on this burgeoning industry. Moderated by Gerald Pascarelli, CFA senior VP, Equity Research at Wedbush Securities,...

In a recent panel discussion at the Benzinga Cannabis Capital Conference, experts in the cannabis industry came together to discuss the evolution of cannabis brands. Moderated by Annie Davis, founder and CEO of Growing Impact, the conversation touched on brand promises, the role of influencers, and...

"California is the winner by a mile, and I hope to strike a balance between low cost, scaled infrastructure, and a CPG portfolio that actually connects with people and brings value to their lives, particularly active, healthy lives," said Carlos "Los" Arias, co-founder & CEO...

The Benzinga Cannabis Capital Conference recently hosted a panel discussion on financial innovation in the cannabis industry, featuring industry experts who shared valuable insights on how to enhance and sustain cannabis businesses. The panel, moderated by Katie Catanese partner at Foley &...

"We're here to save lives," said Geoff Benic, CEO at Safety Strips Inc., a company at the forefront of harm reduction in the midst of the opioid pandemic. Benic was one of the pioneering CEOs who joined Michael Astone, CEO at ArcStone Securities & Investments Corp, in a discussion...

“Happy people make happy plants make happy gummies,” said Bryan Passman, co-founder, and head hunter at Hunter + Esquire, underscoring the foundational belief that a company's human capital is its greatest asset. During September's Benzinga Cannabis Capital Conference in Chicago...

“Appreciate the opportunity to be here today,” said keynote speaker Charlie Bachtell, co-founder & CEO of Cresco Labs Inc (OTCQX: CRLBF) at the September Benzinga Cannabis Capital Conference panel discussion, moderated by Debra Borchardt, executive editor at Green Market Report...

For years, proponents of cannabis legalization have argued that criminalizing the plant serves no rational purpose. Weldon Angelos, a prime example of an individual subjected to unjust incarceration for a cannabis offense, agrees. "If you're in prison for cannabis, it's an injustice,...

The cannabis industry has had its fair share of trials and tribulations over the past few years. Following the recent the Department of Health and Human Services's (HHS) recommendation regarding marijauna rescheduling and legislative develipment related to SAFER Banking Act, one cannot...

While a full-fledged institutional capital infusion in the cannabis industry remains on the horizon, early signs of interest are emerging. What Happened: Speaking exclusively to Benzinga at its Cannabis Capital Conference in late-September, The Arcview Group CEO Jeffrey Finkle said that...

“Well, there was nothing wrong here,” began Jesse Channon, chief commercial officer at The Cannabist Company Holdings Inc (OTC: CCHWF), addressing its recent rebrand from Columbia Care Inc. At the September Benzinga Cannabis Capital Conference in Chicago, Channon sat with T.L...

In a time when product innovation in the cannabis industry is at an ebb, Morgan Paxhia, managing partner at Poseidon Investment Management, sees potential for a resurgence. What Happened: Speaking exclusively to Benzinga at its Cannabis Capital Conference in late September, Paxhia noted that while...

Rescheduling cannabis from a schedule one drug to a schedule three drug was top of mind for former U.S. Rep. Ed Perlmutter, who spoke exclusively to Benzinga at its Cannabis Capital Conference in late September. The former U.S. representative, who has been an influential figure in the cannabis...